Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors

NCT00079352 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: alvocidib
DRUG: gemcitabine hydrochloride
DRUG: irinotecan hydrochloride

Sponsor

National Cancer Institute (NCI)